3.7. Analysis.
Comparison 3 Fluvoxamine versus other SSRIs, Outcome 7 Depression scale ‐ Endpoint score: low=good (acute phase) ‐ missing SDs or skewed data.
Depression scale ‐ Endpoint score: low=good (acute phase) ‐ missing SDs or skewed data | ||||||||
---|---|---|---|---|---|---|---|---|
Study | Depression scale | Fluvoxamine; mean | SD | n | comparator; mean | SD | n | Note |
vs Paroxetine | ||||||||
Ansseau 1994 | HRSD‐21 | 13.2 | 7.3 | 43 | 13.7 | 7.9 | 38 | skewed. |
Kato 2006 | HRSD‐21 | 9.0 | missing | 41 | 4.6 | missing | 39 | |
Kiev 1997 | HRSD‐21 | 10.9 | 7.3 | 29 | 11.5 | 7.4 | 29 | skewed. |
vs Sertraline | ||||||||
Nemeroff 1995 | HRSD‐21 | 14.0 | 7.6 | 46 | 12.2 | 6.5 | 46 | skewed. |
Rossini 2005 | HRSD‐21 | 7.6 | 12.3 | 39 | 11.3 | 11.3 | 45 | skewed. |
vs Fluoxetine | ||||||||
Dalery 2003 | HRSD‐17 | 10.0 | missing | 86 | 11.3 | missing | 91 | |
Rapaport 1996 | HRSD‐21 | 9.6 | missing | 47 | 9.7 | missing | 46 | |
vs Citalopram | ||||||||
Haffmans 1996 | HRSD‐17 | 18.0 | missing | 109 | 16.6 | missing | 108 |